Jim Simons Liminal Bio Sciences Inc. Transaction History

Renaissance Technologies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.32 - $0.5 $3,165 - $4,946	-9,892 Reduced 20.44%	38,500 $13,000
Q3 2022 Nov 14, 2022	SELL	$0.4 - $0.59 $7,203 - $10,624	-18,008 Reduced 27.12%	48,392 $20,000
Q2 2022 Aug 12, 2022	BUY	$0.44 - $0.97 $13,691 - $30,183	31,117 Added 88.19%	66,400 $34,000
Q1 2022 May 13, 2022	SELL	$0.82 - $1.13 $75,541 - $104,100	-92,124 Reduced 72.31%	35,283 $35,000
Q4 2021 Feb 11, 2022	BUY	$0.92 - $2.2 $117,214 - $280,295	127,407 New	127,407 $139,000

234

Ticker LMNL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,042,600
Description
Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom. The company's lead product candidate is fezagepras (PBI-4050), which has been completed Phase I clinical trial for the trea...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.